Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Emphysema Treatment Market Grown from 2024 to 2025?

The market for emphysema treatments has witnessed substantial growth over recent years. It is projected to expand from $5.15 billion in 2024 to $5.43 billion in 2025, registering a compound annual growth rate (CAGR) of 5.6%. Factors such as the effect of the smoking epidemic, advancements in pharmaceutical treatments, the introduction of pulmonary rehabilitation programs, enhanced diagnostic instruments, and increased education and awareness have contributed to the growth during the historical period.

What Growth Rate Is Anticipated for the Emphysema Treatment Market in the Coming Years?

The market for emphysema treatment is anticipated to witness robust expansion in the upcoming years. It is projected to reach “$7.4 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.0%. The growth during the forecast period may be contributed to factors such as trends in the aging population, personalized treatment strategies, broadened therapy availability, emphasis on symptom control, and cooperative health care models. The period under forecast is predicted to see major trends like gene therapy exploration, patient education and empowerment, AI integration, enhanced access to treatment, and development of long-acting medications.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp

Who Are the Leading Companies in the Emphysema Treatment Market?

Major companies operating in the emphysema treatment market include AstraZeneca PLC, Teva Pharmaceutical Industries Ltd., Novartis AG, GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Boehringer Ingelheim GmbH, Mylan N.V., Pfizer Inc., Orion Oyj, Verona Pharma PLC, Pulmonx Corporation, Emphasys Medical Inc., Halozyme Therapeutics Inc., Mariposa Health Limited, Uptake Technologies Inc., Respinova Ltd, Gala Therapeutics Inc., Pulmatrix Inc., Broncus Medical Inc., Holaira Inc., PneumRx Inc., Spiration Inc., Aeris Therapeutics Inc., CSA Medical Inc., Olympus Corporation

What Are the Key Drivers of the Emphysema Treatment Market?

The growth of the emphysema treatment market is expected to be driven by the escalating incidence of chronic obstructive pulmonary disease (COPD). COPD is a collection of disorders leading to obstructions in the airway, resulting in difficulty in breathing, including conditions like emphysema and chronic bronchitis. The use of emphysema therapies is crucial in slowing down the progression of Chronic Obstructive Pulmonary Disease (COPD), as these treatments primarily aim to alleviate symptoms, restore lung functionality, and delay the disease’s progression. As per reports from the Australian Institute of Health and Welfare (AIHW), an Australian agency, it was estimated that approximately 638,000 people, or 2.5% of Australia’s population, had COPD in 2022. By 2023, the disease accounted for 3.6% of the total disease burden, constituting 50% of the complete burden related to respiratory ailments. Moreover, in 2022, COPD was the fundamental cause of 7,691 deaths, amounting to 29.6 deaths per 100,000 individuals and forming 4.0% of all deaths in the country. As a result, the escalating prevalence of COPD positively impacts the emphysema treatment market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10807&type=smp

What Are the Key Market Segments in the Emphysema Treatment Industry?

The emphysema treatment market covered in this report is segmented –

1) By Treatment: Smoking Cessation, Bronchodilators, Steroids, Leukotriene Modifiers, Supplemental Oxygen, Antibiotics, Gene Therapy, Surgery Transplant, Other Treatments

2) By Distribution Channel: Online Providers, Drug Stores and Retail Pharmacies, Hospital Pharmacies

3) By End-User: Clinics, Surgical Centre, Other End-Users

Subsegments:

1) By Smoking Cessation: Nicotine Replacement Therapy (NRT), Prescription Medications, Behavioral Therapy Programs

2) By Bronchodilators: Short-Acting Beta-Agonists (SABAs), Long-Acting Beta-Agonists (LABAs), Anticholinergics

3) By Steroids: Inhaled Corticosteroids (ICS), Oral Corticosteroids, Combination Inhalers

4) By Leukotriene Modifiers: Montelukast, Zafirlukast

5) By Supplemental Oxygen: Portable Oxygen Concentrators, Continuous Flow Oxygen Systems, Pulse Dose Oxygen Systems

6) By Antibiotics: Macrolides, Fluoroquinolones, Tetracyclines

7) By Gene Therapy: Gene Replacement Therapy, Antisense Oligonucleotides

8) By Surgery Transplant: Lung Volume Reduction Surgery (LVRS), Lung Transplantation

9) By Other Treatments: Pulmonary Rehabilitation Programs, Nutritional Support, Palliative Care

What Are the Latest Trends in the Emphysema Treatment Market?

Leading firms in the emphysema market are focusing on the development of minimally invasive procedures to enhance their market prominence. These procedures involve medical surgeries carried out with little interruption to the body’s normal structure. An example of this is the Zephyr Valve surgery launched in January 2022 by Adena Health System, a healthcare organization based in the U.S. This minimally invasive technique serves as an alternative to traditional lung volume reduction surgery and targets individuals with lung hyperinflation often associated with emphysema and COPD. The groundbreaking process involves implanting small, one-directional Zephyr Valves into the lung airways using a bronchoscope. These valves aid in removing the trapped air, preventing further build-up, and providing room for healthier lung sections to develop and enhance breathing efficiency.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report

What Are the Key Regional Markets in the Emphysema Treatment Industry?

North America was the largest region in the emphysema treatment market in 2024. The regions covered in the emphysema treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10807

This Report Delivers Insight On:

1. How big is the emphysema treatment market, and how is it changing globally?

2. Who are the major companies in the emphysema treatment market, and how are they performing?

3. What are the key opportunities and risks in the emphysema treatment market right now?

4. Which products or customer segments are growing the most in the emphysema treatment market?

5. What factors are helping or slowing down the growth of the emphysema treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model